Do individuals with cystic fibrosis (CF) who supplement their diets with omega-3 fatty acid supplements (containing eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)) have improved health outcomes compared with individuals with CF not consuming omega-3 fatty acid supplements?
Role: Student Contributor
Please note that we use cookies to optimize the performance of our website and to help us understand how our site is being used. To learn more about our cookies and how we use them, please read our privacy policy.
DeclineAcceptCustomize...